ESMO 2018 presidential symposium-IMpassion130: atezolizumab+nab-paclitaxel in triple-negative breast cancer

Peter Schmid, Peter Schmid

No abstract available

Keywords: Podcast.

Conflict of interest statement

Competing interests: None declared.